septisse (1 mg + 20 mg)/g aerozol na skórę, roztwór
adamed pharma s.a. - octenidini dihydrochloridum + phenoxyethanolum - aerozol na skórę, roztwór - (1 mg + 20 mg)/g
biotylek 5 mg tabletki
przedsiębiorstwo produkcji farmaceutycznej hasco-lek s.a. - biotinum - tabletki - 5 mg
biotylek max 10 mg tabletki
przedsiębiorstwo produkcji farmaceutycznej hasco-lek s.a. - biotinum - tabletki - 10 mg
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - szczepionki - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. stosowanie tej szczepionki powinno odbywać się zgodnie z oficjalnymi zaleceniami.
lutezin 200 mg tabletki dopochwowe
adamed pharma s.a. - progesteronum - tabletki dopochwowe - 200 mg
lutezin 50 mg tabletki dopochwowe
adamed pharma s.a. - progesteronum - tabletki dopochwowe - 50 mg
lutezin 100 mg tabletki dopochwowe
adamed pharma s.a. - progesteronum - tabletki dopochwowe - 100 mg
progesteron adamed 100 mg tabletki dopochwowe
adamed pharma s.a. - progesteronum - tabletki dopochwowe - 100 mg
progesteron adamed 200 mg tabletki dopochwowe
adamed pharma s.a. - progesteronum - tabletki dopochwowe - 200 mg
ibuprom max rapid 400 mg tabletki powlekane
us pharmacia sp. z o.o. - ibuprofenum - tabletki powlekane - 400 mg